These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 10477547)

  • 1. Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo.
    Nishimura T; Iwakabe K; Sekimoto M; Ohmi Y; Yahata T; Nakui M; Sato T; Habu S; Tashiro H; Sato M; Ohta A
    J Exp Med; 1999 Sep; 190(5):617-27. PubMed ID: 10477547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy.
    Chamoto K; Wakita D; Narita Y; Zhang Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
    Cancer Res; 2006 Feb; 66(3):1809-17. PubMed ID: 16452242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapy.
    Chamoto K; Kosaka A; Tsuji T; Matsuzaki J; Sato T; Takeshima T; Iwakabe K; Togashi Y; Koda T; Nishimura T
    Cancer Sci; 2003 Oct; 94(10):924-8. PubMed ID: 14556668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of tumor eradication by adoptive immunotherapy with T-cell receptor gene-transduced T-helper type 1 cells.
    Chamoto K; Tsuji T; Funamoto H; Kosaka A; Matsuzaki J; Sato T; Abe H; Fujio K; Yamamoto K; Kitamura T; Takeshima T; Togashi Y; Nishimura T
    Cancer Res; 2004 Jan; 64(1):386-90. PubMed ID: 14729649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The critical role of Th1-dominant immunity in tumor immunology.
    Nishimura T; Nakui M; Sato M; Iwakabe K; Kitamura H; Sekimoto M; Ohta A; Koda T; Nishimura S
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S52-61. PubMed ID: 10950149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memory type 2 helper T cells induce long-lasting antitumor immunity by activating natural killer cells.
    Kitajima M; Ito T; Tumes DJ; Endo Y; Onodera A; Hashimoto K; Motohashi S; Yamashita M; Nishimura T; Ziegler SF; Nakayama T
    Cancer Res; 2011 Jul; 71(14):4790-8. PubMed ID: 21646476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific targeting of T helper type 1 (Th1) cells by anti-CD3 x anti-c-ErbB-2 bispecific antibody.
    Ohmi Y; Shiku H; Nishimura T
    Cancer Immunol Immunother; 1999 Nov; 48(8):456-62. PubMed ID: 10550550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined CD4+ Th1 effect and lymphotactin transgene expression enhance CD8+ Tc1 tumor localization and therapy.
    Huang H; Bi XG; Yuan JY; Xu SL; Guo XL; Xiang J
    Gene Ther; 2005 Jun; 12(12):999-1010. PubMed ID: 15789061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of dietary protein antigen on Th1/Th2 balance and cellular immunity.
    Sato M; Iwakabe K; Kimura S; Nishimura T
    Immunol Lett; 1999 Oct; 70(1):29-35. PubMed ID: 10541049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexes.
    Huang H; Hao S; Li F; Ye Z; Yang J; Xiang J
    Immunology; 2007 Feb; 120(2):148-59. PubMed ID: 17274112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble protein but not peptide administration diverts the immune response of a clonal CD4+ T cell population to the T helper 2 cell pathway.
    Degermann S; Pria E; Adorini L
    J Immunol; 1996 Oct; 157(8):3260-9. PubMed ID: 8871620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulation of Th1/Th2 balance in vivo by adoptive transfer of antigen-specific Th1 or Th2 cells.
    Ohta A; Sato N; Yahata T; Ohmi Y; Santa K; Sato T; Tashiro H; Habu S; Nishimura T
    J Immunol Methods; 1997 Nov; 209(1):85-92. PubMed ID: 9448037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice.
    Kumar S; Tarleton RL
    J Immunol; 2001 Apr; 166(7):4596-603. PubMed ID: 11254717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis.
    Iqbal N; Oliver JR; Wagner FH; Lazenby AS; Elson CO; Weaver CT
    J Exp Med; 2002 Jan; 195(1):71-84. PubMed ID: 11781367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
    Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J
    Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary ribonucleotides modulate type 1 and type 2 T-helper cell responses against ovalbumin in young BALB/cJ mice.
    Jyonouchi H; Sun S; Winship T; Kuchan MJ
    J Nutr; 2001 Apr; 131(4):1165-70. PubMed ID: 11285320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary ribonucleotides increase antigen-specific type 1 T-helper cells in the regional draining lymph nodes in young BALB/cJ mice.
    Jyonouchi H; Sun S; Winship T; Kuchan MJ
    Nutrition; 2003 Jan; 19(1):41-6. PubMed ID: 12507638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring the Manipulation of T Helper Immune Responses by
    Tedla MG; Every AL; Scheerlinck JY
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163381
    [No Abstract]   [Full Text] [Related]  

  • 19. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation.
    Hansen G; Berry G; DeKruyff RH; Umetsu DT
    J Clin Invest; 1999 Jan; 103(2):175-83. PubMed ID: 9916129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of IFNgamma-depleted CD4(+) T cells together with CD8(+) T cells leads to rejection of murine kidney sarcoma in mice.
    Klugewitz K; Scheffold A; Radbruch A; Hamann A
    Int J Cancer; 2000 Sep; 87(5):673-9. PubMed ID: 10925361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.